Mediterranean diet adherence and dietary fat intake in relation to lung cancer outcomes: a prospective cohort study
Open Access
- 1 June 2026
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 17 (12) , 5650-5661
Abstract
Background: Lung cancer continues to be the most frequently diagnosed malignancy globally and a major contributor to cancer-related deaths. Although dietary factors have been increasingly implicated in its development, evidence for the Mediterranean diet (MED) and specific fat subtypes remains limited. Objectives: To examine the associations between MED adherence and dietary fat intakes with lung cancer incidence, mortality, and survival. Methods: We included 191 139 cancer-free participants from the UK Biobank. The validated Oxford WebQ 24-hour dietary questionnaire was used to measure dietary intake. The adherence of MED was assessed by the Alternate Mediterranean diet (AMED) score. Total dietary fat and fat subtype intakes were calculated as a proportion of total energy intake. Associations between dietary factors and lung cancer outcomes were analyzed using adjusted Cox regression. Results: After full adjustment, greater adherence to the MED was associated with a lower lung cancer risk (HRQ4 vs. Q1: 0.66; 95% CI: 0.58–0.77), and lower lung cancer-specific mortality (HRQ4 vs. Q1: 0.61; 95% CI: 0.50–0.74). Higher polyunsaturated fatty acids (PUFAs) intake was linked to lower lung cancer risk (HRQ4 vs. Q1: 0.82; 95% CI: 0.71–0.95) and mortality (HRQ4 vs. Q1: 0.77; 95% CI: 0.63–0.94), whereas higher saturated fatty acids (SFAs) intake was associated with increased lung cancer risk (HRQ4 vs. Q1: 1.25; 95% CI: 1.09–1.45) and mortality (HRQ4 vs. Q1: 1.23; 95% CI: 1.01–1.49). In isocaloric substitution analyses, replacing 1% of energy from SFAs with PUFAs was associated with a 9% and 10% lower risk of lung cancer incidence and mortality. Among participants who developed lung cancer, individuals with high pre-diagnosis AMED scores and PUFAs intake had better post-diagnosis survival than those with low AMED scores and low PUFAs intake (HR = 0.77; 95% CI: 0.61–0.96). Conclusions: Adherence to the MED and higher PUFAs intake were independently related to lower risk of lung cancer and reduced lung cancer-specific mortality. The combination of greater MED adherence and higher PUFAs intake may provide additional benefits for lung cancer post-diagnosis survival. These findings imply that dietary modifications might have a role in both the onset and progression of lung cancer. Further studies are warranted to clarify the mechanistic pathways and inform the development of dietary recommendations.Keywords
Funding Information
- Key Research and Development Program of Zhejiang Province (2020C03002)
This publication has 51 references indexed in Scilit:
- Adherence to the Mediterranean Diet and Obesity-Linked Cancer Risk in EPICJAMA Network Open, 2025
- Diet quality patterns and chronic kidney disease incidence: a UK Biobank cohort studyThe American Journal of Clinical Nutrition, 2024
- Dietary Patterns and Risk of Lung Cancer: A Systematic Review and Meta-Analyses of Observational StudiesCurrent Nutrition Reports, 2023
- Cancer, Phase Angle and Sarcopenia: The Role of Diet in Connection with Lung Cancer PrognosisLung, 2022
- Nut consumption in association with overall mortality and recurrence/disease‐specific mortality among long‐term breast cancer survivorsInternational Journal of Cancer, 2021
- Diet quality and all-cause and cancer-specific mortality in cancer survivors and non-cancer individuals: the Multiethnic Cohort StudyEuropean Journal of Nutrition, 2021
- Description of the updated nutrition calculation of the Oxford WebQ questionnaire and comparison with the previous version among 207,144 participants in UK BiobankEuropean Journal of Nutrition, 2021
- Effect of a Nutritional and Behavioral Intervention on Energy-Reduced Mediterranean Diet Adherence Among Patients With Metabolic SyndromeJAMA, 2019
- Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: Randomised trialClinical Nutrition, 2014
- Basic aspects of tumor cell fatty acid-regulated signaling and transcription factorsCancer and Metastasis Reviews, 2011